diabetes management algorithm step 2 medicine shelf glyburide semaglutide American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type – 2023 Update Diabetes Canada | Clinical Practice

Dulaglutide vs semaglutide Semaglutide generally shows superior efficacy in reducing HbA1c and promoting weight loss compared to Dulaglutide, though both are highly effective, once-weekly GLP-1 receptor agonists for type 2 diabetes

[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Granhall C, Donsmark M, Blicher TM, Golor G, Sndergaard FL, Thomsen M, Bkdal TA

The rapid growth trajectory from initial filings in August 2023 to nearly 2,000 cases by August 2025 (with more ozempic lawsuits expected) reflects both the widespread use of these medications (with over 33 million patient-years of semaglutide exposure globally) and the severity of reported injuries

event rate 0.08 events/person-years of observation with IcoSema vs 0.09 events/person-years of observation with semaglutide)